369 related articles for article (PubMed ID: 15986403)
1. Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.
Zoller H; McFarlane I; Theurl I; Stadlmann S; Nemeth E; Oxley D; Ganz T; Halsall DJ; Cox TM; Vogel W
Hepatology; 2005 Aug; 42(2):466-72. PubMed ID: 15986403
[TBL] [Abstract][Full Text] [Related]
2. Hepatic iron concentration, fibrosis and response to venesection associated with the A77D and V162del "loss of function" mutations in ferroportin disease.
Lim FL; Dooley JS; Roques AW; Grellier L; Dhillon AP; Walker AP
Blood Cells Mol Dis; 2008; 40(3):328-33. PubMed ID: 18160317
[TBL] [Abstract][Full Text] [Related]
3. Genetic and clinical heterogeneity of ferroportin disease.
Cremonesi L; Forni GL; Soriani N; Lamagna M; Fermo I; Daraio F; Galli A; Pietra D; Malcovati L; Ferrari M; Camaschella C; Cazzola M
Br J Haematol; 2005 Dec; 131(5):663-70. PubMed ID: 16351644
[TBL] [Abstract][Full Text] [Related]
4. Identification of mutations in SLC40A1 that affect ferroportin function and phenotype of human ferroportin iron overload.
Mayr R; Griffiths WJ; Hermann M; McFarlane I; Halsall DJ; Finkenstedt A; Douds A; Davies SE; Janecke AR; Vogel W; Cox TM; Zoller H
Gastroenterology; 2011 Jun; 140(7):2056-63, 2063.e1. PubMed ID: 21396368
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic expression of ferroportin disease in a family with the N144H mutation.
Rosmorduc O; Wendum D; Arrivé L; Elnaggar A; Ennibi K; Hannoun L; Charlotte F; Grangé JD; Poupon R
Gastroenterol Clin Biol; 2008 Mar; 32(3):321-7. PubMed ID: 18403150
[TBL] [Abstract][Full Text] [Related]
6. Mutation analysis of hepcidin and ferroportin genes in Italian prospective blood donors with iron overload.
Duca L; Delbini P; Nava I; Vaja V; Fiorelli G; Cappellini MD
Am J Hematol; 2009 Sep; 84(9):592-3. PubMed ID: 19610021
[TBL] [Abstract][Full Text] [Related]
7. A novel missense mutation in SLC40A1 results in resistance to hepcidin and confirms the existence of two ferroportin-associated iron overload diseases.
Létocart E; Le Gac G; Majore S; Ka C; Radio FC; Gourlaouen I; De Bernardo C; Férec C; Grammatico P
Br J Haematol; 2009 Nov; 147(3):379-85. PubMed ID: 19709084
[TBL] [Abstract][Full Text] [Related]
8. Functional consequences of ferroportin 1 mutations.
Liu XB; Yang F; Haile DJ
Blood Cells Mol Dis; 2005; 35(1):33-46. PubMed ID: 15935710
[TBL] [Abstract][Full Text] [Related]
9. Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features.
Sham RL; Phatak PD; West C; Lee P; Andrews C; Beutler E
Blood Cells Mol Dis; 2005; 34(2):157-61. PubMed ID: 15727899
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation in ferroportin implicated in iron overload.
Wallace DF; Dixon JL; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN
J Hepatol; 2007 May; 46(5):921-6. PubMed ID: 17383046
[TBL] [Abstract][Full Text] [Related]
11. Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.
Pietrangelo A
Gastroenterology; 2010 Aug; 139(2):393-408, 408.e1-2. PubMed ID: 20542038
[TBL] [Abstract][Full Text] [Related]
12. A novel ferroportin mutation in a Canadian family with autosomal dominant hemochromatosis.
Morris TJ; Litvinova MM; Ralston D; Mattman A; Holmes D; Lockitch G
Blood Cells Mol Dis; 2005; 35(3):309-14. PubMed ID: 16111902
[TBL] [Abstract][Full Text] [Related]
13. [Hepcidin--the discovery of a small protein with a pivotal role in iron homeostasis].
Sela BA
Harefuah; 2008 Mar; 147(3):261-6, 276. PubMed ID: 18488871
[TBL] [Abstract][Full Text] [Related]
14. New insights into the regulation of iron homeostasis.
Deicher R; Hörl WH
Eur J Clin Invest; 2006 May; 36(5):301-9. PubMed ID: 16634833
[TBL] [Abstract][Full Text] [Related]
15. A study of genes that may modulate the expression of hereditary hemochromatosis: transferrin receptor-1, ferroportin, ceruloplasmin, ferritin light and heavy chains, iron regulatory proteins (IRP)-1 and -2, and hepcidin.
Lee PL; Gelbart T; West C; Halloran C; Felitti V; Beutler E
Blood Cells Mol Dis; 2001; 27(5):783-802. PubMed ID: 11783942
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization.
Nemeth E; Tuttle MS; Powelson J; Vaughn MB; Donovan A; Ward DM; Ganz T; Kaplan J
Science; 2004 Dec; 306(5704):2090-3. PubMed ID: 15514116
[TBL] [Abstract][Full Text] [Related]
17. Pro-hepcidin is unable to degrade the iron exporter ferroportin unless maturated by a furin-dependent process.
Gagliardo B; Kubat N; Faye A; Jaouen M; Durel B; Deschemin JC; Canonne-Hergaux F; Sari MA; Vaulont S
J Hepatol; 2009 Feb; 50(2):394-401. PubMed ID: 19070914
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and molecular pathophysiology of autosomal dominant hemochromatosis caused by a novel ferroportin mutation.
Griffiths WJ; Mayr R; McFarlane I; Hermann M; Halsall DJ; Zoller H; Cox TM
Hepatology; 2010 Mar; 51(3):788-95. PubMed ID: 19937651
[TBL] [Abstract][Full Text] [Related]
19. Iron homeostasis and erythropoiesis.
Wrighting DM; Andrews NC
Curr Top Dev Biol; 2008; 82():141-67. PubMed ID: 18282520
[TBL] [Abstract][Full Text] [Related]
20. A mouse model of juvenile hemochromatosis.
Huang FW; Pinkus JL; Pinkus GS; Fleming MD; Andrews NC
J Clin Invest; 2005 Aug; 115(8):2187-91. PubMed ID: 16075059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
